Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced an upcoming presentation of non-clinical data for K‑679, its novel antibody drug-loaded unimicelle conjugate (ADUC) ...
Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.
Antibody–drug conjugates (ADCs) represent one of the most transformative advances in precision oncology over the past two decades and are increasingly positioned to replace conventional chemotherapy ...
U.S. FDA Fast Track designation granted to ZW191, an antibody-drug conjugate targeting folate receptor-α (FRα), for the treatment of patients ...
The conjugate training method is a weightlifting program that’s primarily designed to build strength. It’s sometimes referred to as the Westside-Barbell Conjugate Method or Westside’s Conjugate Method ...
Zymeworks has won the Food and Drug Administration's fast-track designation for its ZW191 antibody-drug conjugate for patients with advanced or metastatic platinum-resistant ovarian cancer.
An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results